|
Institutional Biosafety Committee (IBC)
The TWU Institutional Biosafety Committee (IBC) is
responsible for oversight of all laboratories and research
projects that involve recombinant DNA (rDNA) or biohazardous
agents.
Faculty and staff with teaching or research laboratories
containing chemicals used as reagents or for purposes other than
cleaning are required to register their laboratories annually.
If either rDNA or biohazardous agents are present in the
laboratory, the researcher will be notified by the IBC that (1)
the project is exempt from NIH Guidelines (the registration form
will be returned with approval signature), or (2) a full
application to the IBC must be submitted for the project.
Any research at Texas Woman’s University (TWU), including
educational activities using recombinant DNA or biohazardous
agents must be approved by the Institutional Biosafety Committee
(IBC) prior to acquisition of the agents or initiation of the
activity. Non-compliance with rDNA guidelines can jeopardize all
NIH funding at TWU.
Definitions:
Biohazardous Agents: any microorganism, virus,
infectious substance, or toxin that is biological in nature and
capable of producing deleterious effects upon humans, animals,
plants, or the environment.
Recombinant DNA: Recombinant DNA research involves the
joining of natural or synthetic DNA/RNA segments outside the
cell that can then be introduced and replicated in a living cell
and includes derivatives that occur upon replication. This
includes the use of recombinant DNA molecules.
Institutional Biosafety Policy
Registration Form
Application Form & Instructions
Continuation Form
IBC Required Online Training
IBC
Committee
IBC Purchasing
Approval Form
Resources:
Biosafety in Biomedical and
Microbiological Laboratories
NIH Guidelines for Research Involving Recombinant DNA
Laboratory Safety Monograph
CDC
Biosafety Recommendations
|